How it works
Acquisition of a product portfolio based on the ELISA immunodiagnostic technology from Siemens and access to Siemens' ELISA clients.
We are very excited to acquire the Siemens Healthineers ELISA business. We think this deal would perfectly fit with our long-term strategy aimed at expanding our customer base leveraging on our extensive CLIA specialities menu and LIAISON Platforms.
Convert clients adopting Siemens’ ELISA products to our proprietary CLIA solutions, leveraging on the completeness of our CLIA menu and our LIAISON platforms.